0001628280-20-009547.txt : 20200616
0001628280-20-009547.hdr.sgml : 20200616
20200616164740
ACCESSION NUMBER: 0001628280-20-009547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20200616
DATE AS OF CHANGE: 20200616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huber Reid M
CENTRAL INDEX KEY: 0001607052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 20966966
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN
STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_159234044255883.xml
FORM 4
X0306
4
2020-06-15
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001607052
Huber Reid M
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
1
0
0
0
Stock Option (right to buy)
8.42
2020-06-15
4
A
0
6500
0
A
2030-06-14
Common Stock
6500.0
6500
D
The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date.
/s/ Shane M. Ward, Attorney-in-Fact
2020-06-16